NATURAL ALTERNATIVES INTERNATIONAL INC (NAII)

Nasdaq Pharmaceutical Pharmaceutical Chemicals SIC: 2833
D
Pipeline Grade

Financial Position (from SEC Filings)

$9.2M
Cash & Equivalents
$7.9M
Quarterly Burn Rate
4 mo
Est. Cash Runway
$14M
Market Cap

Estimated from most recent SEC quarterly filing. View SEC filings

Drug Pipeline (0 Assets)

No drugs indexed yet. Pipeline data is populated from ClinicalTrials.gov and openFDA.

Upcoming Catalysts

No upcoming catalysts detected for this company.

Active Clinical Trials (1)

NCT #TitlePhaseStatusEnrollment
NCT01439659 Juice Plus+ and Juice Plus+ Complete in Ovarian Cancer PHASE2 Active Not Recruiting 75

Source: ClinicalTrials.gov. Trial status last updated by sponsor — may not reflect current state.

More Analysis

AI Stock Score

SEC EDGAR fundamental analysis with Claude AI & ChatGPT ratings for NAII.

SEC EDGAR Filings

All SEC filings for NATURAL ALTERNATIVES INTERNATIONAL INC on EDGAR.

Full Calendar

View all upcoming FDA catalysts across all biotech companies.